Fund shareholders of Harvard Bioscience Inc
ISIN US4169062043 · United States · LEI 549300VLGB1D47GGC642
- Fund shareholders
- 8
- Of which ETFs
- 2 6 other funds
- Value held
- 877.8K $
- Share of capital
- 3.9 % of 4.6M shares on Aug 4, 2026
Other securities from the same issuer : HARVARD BIOSCIENCE INC (US4169061052)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 123,470 | 601.3K $ | 2.71 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 39,843 | 194K $ | 0.00 % | 0.88 % | as of Mar 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 8,783 | 42.8K $ | 0.04 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 4,000 | 19.5K $ | 0.09 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 1,366 | 8.7K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 1,029 | 6.6K $ | 0.02 % | as of Apr 30, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 683 | 3.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 258 | 1.6K $ | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 0.09 % | as of Mar 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
Institutional managers
30 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| WEBER CAPITAL MANAGEMENT LLC /ADV | 320,037 | 1.6M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 179,614 | 873 $ | as of Mar 31, 2026 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 124,810 | 607.8K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 114,117 | 555.8K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 101,427 | 493.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 62,226 | 303K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 59,511 | 289.9K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 46,332 | 225.6K $ | as of Mar 31, 2026 |
| Williams & Novak, LLC | 27,052 | 137.7K $ | as of Mar 31, 2026 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 27,021 | 131.6K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 23,830 | 116.1K $ | as of Mar 31, 2026 |
| RBF Capital, LLC | 16,000 | 77.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 14,932 | 72.7K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 10,230 | 49.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,405 | 40.9K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 6,273 | 30.6K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,463 | 20.8K $ | as of Mar 31, 2026 |
| FMR LLC | 3,274 | 15.9K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 2,182 | 10.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,628 | 7.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,152 | 5.6K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 866 | 4.2K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 855 | 4K $ | as of Mar 31, 2026 |
| Brown Shipley& Co Ltd | 478 | 2.3K $ | as of Mar 31, 2026 |
| NISA INVESTMENT ADVISORS, LLC | 228 | 1.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Harvard Bioscience Inc". https://titelia.com/en/stocks/harvard-bioscience-inc-US4169062043